The DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index.
Sarcopenic obesity: molecular clues to a better understanding of its pathogenesis?
Abstract
An age-dependent decline in skeletal muscle mass, strength, and endurance during the aging process is a physiological development, but several factors may exacerbate this process, leading to the threatening state of sarcopenia, frailty, and eventually higher mortality rates. Obesity appears to be such a promoting factor and has been linked in several studies to sarcopenia. The reason for this causal association remains poorly understood. Notwithstanding the fact that a higher body mass might simply lead to diminished physical activity and therefore contribute to a decline in skeletal muscle, several molecular mechanisms have been hypothesized. There could be an obesity derived intracellular lipotoxicity (i.e., elevated intramuscular levels of lipids and their derivatives), which induces apoptosis by means of an elevated oxidative stress. Paracrine mechanisms and inflammatory cytokines, such as CRP and IL-6 could be confounders of the actual underlying pathological mechanism. Due to a cross-talk of the hypothalamo-pituitary axis with nutritional status, obese subjects are more in a catabolic state of metabolism, with a higher susceptibility to muscle wasting under energy restriction. Obesity induces insulin resistance in the skeletal muscle, which consequently leads to perturbed metabolism, and misrouted signaling in the muscle cells. In obesity, muscle progenitor cells could differentiate to an adipocyte-like phenotype as a result of paracrine signals from (adipo)cytokines leading to a reduced muscular renewal capacity. The present review outlines current knowledge concerning possible pathways, which might be involved in the molecular pathogenesis of sarcopenic obesity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The regeneration potential of muscle is impaired, which might promote fibrosis, thereby promoting insulin resistance76–79, partially owing to impaired mitochondrial fatty acid oxidation and increased lipolysis76,80.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [77]
In the citing paper
“These cytokines induce muscle atrophy by increasing apoptosis and upregulating proteosomal decay of filament proteins [42].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [42]
In the citing paper
“Thus, SO decreases the physical functional capacity to a higher degree than sarcopenia or obesity separately [13, 14].”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [14]
In the citing paper
“Also, adiponectin and growth hormone (GH) decrease their secretion in obesity and aging, inducing adverse effects on muscle protein synthesis.”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [14]
In the citing paper
“TNF-α is a proinflammatory cytokine that increases in aging and obesity, promotes protein degradation, decreases protein synthesis, and inhibits myogenic differentiation [14, 45].”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [14]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Wenz, T., Rossi, S. G., Rotundo, R. L., Spiegelman, B. M., & Moraes, C. T. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911570106 · Cited by 600 · cited 3×
“Transgene animals showed a lower fat percentage, together with a higher mitochondrial capacity and a higher capacity for oxidative phosphorylation and increased insulin sensitivity, suggesting a PGC-1a-mediated mitochondrial dysfunction in muscular aging (Wenz et al. 2009).”
BackgroundInfluentialRetractedSarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601 · cited 4×
“8 or\1 m/s) for diagnosing of sarcopenia (Cruz-Jentoft et al. 2010; Fielding et al. 2011).”
BackgroundInfluentialAging: a theory based on free radical and radiation chemistry
Harman, D. (1956) · Journal of Gerontology · doi:10.1093/geronj/11.3.298 · Cited by 8,567 · cited 2×
“increased reactive oxygen species formation (ROS), an age-dependent decrease in central mitochondrial regulator peroxisome-proliferator-activated-receptor-c coactivator 1 a (PGC-1a) and induced mitochondrial apoptosis of muscle cells are important (Harman 1956; Anderson and Prolla 2009; Marzetti et al. 2010).”
BackgroundAmerican College of Sports Medicine position stand
Otis, C. L. (1997) · Medical Entomology and Zoology · Cited by 4,407
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238 · cited 3×
“Adiponectin increases insulin sensitivity by facilitating glucose uptake in skeletal muscle and adipose tissue and stimulates fatty acid oxidation (Yamauchi et al. 2002).”
BackgroundFielding, R. A., Vellas, B., Evans, W. J., Bhasin, S., Morley, J. E., Newman, A. B., Abellan van Kan, G., Andrieu, S., Bauer, J., Breuille, D., et al. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.01.003 · Cited by 3,256 · cited 3×
“8 or\1 m/s) for diagnosing of sarcopenia (Cruz-Jentoft et al. 2010; Fielding et al. 2011).”
BackgroundInfluentialSelf-citationAdipocytokines: mediators linking adipose tissue, inflammation and immunity
Tilg, H., & Moschen, A. R. (2006) · Nature Reviews Immunology · doi:10.1038/nri1937 · Cited by 3,188 · cited 6×
“It decreases the inflammatory response by inhibiting TNFa and interleukin-c (ILc) secretion and elevates production of anti-inflammatory cytokines, such as IL-10 and IL-1 receptor antagonist, by human monocytes, macrophages, and dendritic cells (Tilg and Moschen 2006).”
BackgroundInfluentialCloning of adiponectin receptors that mediate antidiabetic metabolic effects
Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M., et al. (2003) · Nature · doi:10.1038/nature01705 · Cited by 3,176
DONNELLY, J. E., BLAIR, S. N., JAKICIC, J. M., MANORE, M. M., RANKIN, J. W., & SMITH, B. K. (2009) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181949333 · Cited by 2,658 · cited 1×
“Actually in older people with obesity, it leads to muscle mass gain and improves body composition (Donnelly et al. 2009).”
BackgroundMuscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
Pedersen, B. K., & Febbraio, M. A. (2008) · Physiological Reviews · doi:10.1152/physrev.90100.2007 · Cited by 2,388 · cited 1×
“After release in the blood stream, IL-6 enhances gluconeogenesis in the liver and lipolysis in adipose tissue (Pedersen and Febbraio 2008).”
Background
Cited by
Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies
Batsis, J. A., & Villareal, D. T. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0062-9 · Cited by 1,382
Kalinkovich, A., & Livshits, G. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.008 · Cited by 882
Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review
Li, C., Yu, K., Shyh‐Chang, N., Jiang, Z., Liu, T., Ma, S., Luo, L., Guang, L., Liang, K., Ma, W., et al. (2022) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12901 · Cited by 626
Heymsfield, S. B., Gonzalez, M. C., Lu, J., Jia, G., & Zheng, J. (2015) · Proceedings of the Nutrition Society · doi:10.1017/s0029665115000129 · Cited by 483
Mitochondria and ageing: Role in heart, skeletal muscle and adipose tissue
Boengler, K., Kosiol, M., Mayr, M., Schulz, R., & Rohrbach, S. (2017) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12178 · Cited by 421
Hong, S.-H., & Choi, K. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020494 · Cited by 390
“These cytokines induce muscle atrophy by increasing apoptosis and upregulating proteosomal decay of filament proteins [42].”
BackgroundOsteoporosis and Sarcopenia Increase Frailty Syndrome in the Elderly
Greco, E. A., Pietschmann, P., & Migliaccio, S. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00255 · Cited by 335
“The increased body and muscle fat are associated with insulin resistance and low-grade chronic inflammation, with an increase in many specific and unspecific inflammatory parameters, like C reactive protein (CRP), fibrinogen, interleukin-6 (IL-6), and tumor-necrosis-factor alpha (TNF-α), which lead to the decrease in…”
BackgroundInfluentialSarcopenia: Current Concepts and Imaging Implications
Boutin, R. D., Yao, L., Canter, R. J., & Lenchik, L. (2015) · American Journal of Roentgenology · doi:10.2214/ajr.15.14635 · Cited by 323
“toxicity [89].”
Collins, K. H., Herzog, W., MacDonald, G. Z., Reimer, R. A., Rios, J. L., Smith, I. C., Zernicke, R. F., & Hart, D. A. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00112 · Cited by 308
“Although the age-dependent declines in muscle structure and strength are well-documented, the mechanism by which MetS results in sarcopenic obesity remains to be clarified (Kob et al., 2014).”
BackgroundFrailty and the endocrine system
Clegg, A., & Hassan-Smith, Z. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30110-4 · Cited by 266
Livshits, G., & Kalinkovich, A. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100980 · Cited by 237
Aging, nutritional status and health
Leslie, W., & Hankey, C. (2015) · Healthcare · doi:10.3390/healthcare3030648 · Cited by 211
“Given that the aging process results in loss of muscle mass, it is essential that weight loss programmes do not induce further loss resulting in the development of “sarcopenic obesity” where the adult has lowered muscle mass, within a given BMI and impaired functional capacity [47] Preservation of muscle mass can be a…”
BackgroundSarcopenia – The search for emerging biomarkers
Kalinkovich, A., & Livshits, G. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.05.001 · Cited by 187
“In recent years, sarcopenic obesity has received increased attention as a risk factor for the impairment of physical performance, leading to frequent fragility fractures and even being a predictor for worse clinical outcomes when compared with sarcopenia or obesity alone (Biolo et al., 2014; Binkley et al., 2013; Ilic…”
Physical Activity and Sarcopenic Obesity: Definition, Assessment, Prevalence and Mechanism
Lee, D.-C., Shook, R. P., Drenowatz, C., & Blair, S. N. (2016) · Future Science OA · doi:10.4155/fsoa-2016-0028 · Cited by 177
Nutrition and Muscle in Cirrhosis
Anand, A. C. (2017) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2017.11.001 · Cited by 172
Kwak, J. Y., & Kwon, K.-S. (2019) · Annals of Geriatric Medicine and Research · doi:10.4235/agmr.19.0028 · Cited by 171
Freiberger, E., Goisser, S., Porzel, S., Volkert, D., Kemmler, W., Sieber, C., & Bollheimer, C. (2015) · Clinical Interventions in Aging · doi:10.2147/cia.s82454 · Cited by 162
“Aerobic exercise would address the metabolic pathway in older persons with sarcopenia.(27) Evidence on aerobic exercise targeting sarcopenia in older persons is just developing and will hopefully evolve in the upcoming years.”
InfluentialSelf-citationSarcopenia and Cognitive Function: Role of Myokines in Muscle Brain Cross-Talk
Scisciola, L., Fontanella, R. A., Surina, S., Cataldo, V., Paolisso, G., & Barbieri, M. (2021) · Life · doi:10.3390/life11020173 · Cited by 178
“FAs, in the form of triglycerides (TG), diacylglycerols (DAG), and ceramides, accumulate both in intermuscular adipose tissue (IMAT) as in intramyocellular lipids (IMCLs), inducing impaired single-fiber contractility via mitochondrial dysfunction, impaired β-oxidation of FAs, and increased reactive oxygen species (ROS…”
BackgroundKemmler, W., Kohl, M., Fröhlich, M., Jakob, F., Engelke, K., von Stengel, S., & Schoene, D. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4027 · Cited by 139
“However, considering that sarcopenia and sarcopenic obesity (dependent on the corresponding definition of obesity, 30% to 50% of our cohort feature sarcopenic obesity [SO]) include aspects of inflammation,((82)) mitochondrial abnormalities,((83)) and oxidative stress,((84)) factors potentially decreasing muscle and/or…”
BackgroundSandini, M., Bernasconi, D. P., Fior, D., Molinelli, M., Ippolito, D., Nespoli, L. C., Caccialanza, R., & Gianotti, L. V. (2016) · Nutrition · doi:10.1016/j.nut.2016.04.002 · Cited by 139
KEMMLER, W. K., Weißenfels, A., Teschler, M., Willert, S., Bebenek, M., Shojaa, M., Kohl, M., Freiberger, E., Sieber, C. C., & von Stengel, S. (2017) · Clinical Interventions in Aging · doi:10.2147/cia.s137987 · Cited by 144
Self-citationLiver alanine catabolism promotes skeletal muscle atrophy and hyperglycaemia in type 2 diabetes
Okun, J. G., Rusu, P. M., Chan, A. Y., Wu, Y., Yap, Y. W., Sharkie, T., Schumacher, J., Schmidt, K. V., Roberts‐Thomson, K. M., Russell, R., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00369-9 · Cited by 128
Sleep and frailty risk: a systematic review and meta-analysis
Pourmotabbed, A., Boozari, B., Babaei, A., Asbaghi, O., Campbell, M. S., Mohammadi, H., Hadi, A., & Moradi, S. (2020) · Sleep And Breathing · doi:10.1007/s11325-020-02061-w · Cited by 124
“Obesity-derived intracellular lipo-toxicity resulted from changes in body composition in frail or sarcopenic individuals, thereby leading to elevated inflammation, oxidative stress, and insulin resistance in older adults [52].”
BackgroundGheller, B. J. F., Riddle, E. S., Lem, M. R., & Thalacker-Mercer, A. E. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071715-050901 · Cited by 98
Exploring the Impact of Obesity on Skeletal Muscle Function in Older Age
Morgan, P. T., Smeuninx, B., & Breen, L. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.569904 · Cited by 118
Prediction of sarcopenia using a combination of multiple serum biomarkers
Kwak, J. Y., Hwang, H., Kim, S., Choi, J. Y., Lee, S.-M., Bang, H., Kwon, E., Lee, K., Chung, S. G., & Kwon, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-26617-9 · Cited by 113
Sarcopenic obesity: An appraisal of the current status of knowledge and management in elderly people
Molino, S., Dossena, M., Buonocore, D., & Verri, M. (2016) · The Journal of nutrition, health and aging · doi:10.1007/s12603-015-0631-8 · Cited by 91
Harnessing Muscle–Liver Crosstalk to Treat Nonalcoholic Steatohepatitis
Chakravarthy, M. V., Siddiqui, M. S., Forsgren, M. F., & Sanyal, A. J. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.592373 · Cited by 107
“These cytokines negatively impact skeletal muscle by upregulating proteasomal decay of filament proteins and promoting apoptosis (123).”
BackgroundSarcopenic obesity: research advances in pathogenesis and diagnostic criteria
Xie, W.-Q., Xiao, G.-L., Fan, Y.-B., He, M., Lv, S., & Li, Y.-S. (2021) · Aging Clinical and Experimental Research · doi:10.1007/s40520-019-01435-9 · Cited by 86
Hita-Contreras, F., Bueno-Notivol, J., Martínez-Amat, A., Cruz-Díaz, D., Hernandez, A. V., & Pérez-López, F. R. (2018) · Maturitas · doi:10.1016/j.maturitas.2018.07.007 · Cited by 86
KEMMLER, W. K., Kohl, M., Jakob, F. J., Engelke, K., & von Stengel, S. (2020) · Nutrients · doi:10.3390/nu12082341 · Cited by 102
“obesity are related to inflammation [87], mitochondrial abnormalities, [88] and oxidative stress [89] (applying a reasonable cut-off for (sarcopenic) obesity (i.”
BackgroundThe critical role of oxidative stress in sarcopenic obesity
Gonzalez, A., Simon, F., Achiardi, O., Vilos, C., Cabrera, D., & Cabello-Verrugio, C. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/4493817 · Cited by 79
“Also, in aging, there are decreased rest metabolic rates (4% per decade after the age of 50 years), reduced motor neurons, and skeletal muscle metabolic adaptations, which could also favor obesity and loss of muscle mass [14, 31, 37, 73, 74].”
BackgroundInfluentialInteraction between sarcopenia and nonalcoholic fatty liver disease
Joo, S. K., & Kim, W. (2023) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0358 · Cited by 78
Sarcopenia in post-menopausal women: Is there any role for vitamin D?
Anagnostis, P. G., Dimopoulou, C., Karras, S. Ν., Lambrinoudaki, I. V., & Goulis, D. G. (2015) · Maturitas · doi:10.1016/j.maturitas.2015.03.014 · Cited by 88
Overweight in elderly people induces impaired autophagy in skeletal muscle
Potes, Y., de Luxán-Delgado, B., Rodriguez-González, S., Guimarães, M. R. M., Solano, J. J., Fernández-Fernández, M., Bermúdez, M., Boga, J. A., Vega-Naredo, I., & Coto-Montes, A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.05.018 · Cited by 67
Ursolic acid and mechanisms of actions on adipose and muscle tissue: a systematic review
Katashima, C. K., Silva, V. R. R., Gomes, T. L. N., Pichard, C., & Pimentel, G. D. (2017) · Obesity Reviews · doi:10.1111/obr.12523 · Cited by 70
Yin, Y.-H., Liu, J. Y. W., & Välimäki, M. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110937 · Cited by 61
Serum Leptin Concentration is Associated with Incident Frailty in Older Adults
Lana, A., Valdés-Bécares, A., Soto, A. B., Rodríguez‐Artalejo, F., & López‐García, E. (2017) · Aging and Disease · doi:10.14336/ad.2016.0819 · Cited by 66
Batsis, J. A., Haudenschild, C., Roth, R. M., Gooding, T., Roderka, M. N., Masterson, T. D., Brand, J., Lohman, M. C., & MacKenzie, T. A. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2020.09.008 · Cited by 63
Standley, R. A., Distéfano, G., Pereira, S. L., Tian, M., Kelly, O. J., Coen, P. M., Deutz, N. E. P., Wolfe, R. R., & Goodpaster, B. H. (2017) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00192.2017 · Cited by 69
Impact of Sarcopenia on Non-Alcoholic Fatty Liver Disease
Iwaki, M., Kobayashi, T., Nogami, A., Saito, S., Nakajima, A., & Yoneda, M. (2023) · Nutrients · doi:10.3390/nu15040891 · Cited by 69
“Adiponectin promotes insulin sensitivity by enhancing glucose uptake in skeletal muscle and adipose tissue and increases fatty acid oxidation [54,56].”
BackgroundAzevedo, V. Z., Silaghi, C. A., Maurel, T., Silaghi, H., Ratziu, V., & Pais, R. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.774030 · Cited by 67
“In addition, IL-6 may be secreted by the skeletal muscle during the physical exercise and after its outflow in the blood stream increases liver gluconeogenesis and adipose tissue lipolysis (76, 90).”
BackgroundInfluentialSarcopenia: Molecular regulatory network for loss of muscle mass and function
Wu, J., Ding, P., Wu, H., Yang, P., Guo, H., Tian, Y., Meng, L., & Zhao, Q. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1037200 · Cited by 64
“In response to aging and chronic inflammation, the increased fat content in the body is redistributed, resulting in increased visceral fat content and infiltration of skeletal muscle fat (96).”
BackgroundCollins, K. H., Hart, D. A., Reimer, R. A., Seerattan, R. A., Waters‐Banker, C., Sibole, S. C., & Herzog, W. (2016) · Journal of Orthopaedic Research® · doi:10.1002/jor.23230 · Cited by 59
Melatonin as a Potential Agent in the Treatment of Sarcopenia
Coto‐Montes, A. M., Boga, J. A., Tan, D., & Reiter, R. J. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101771 · Cited by 59
“Also, alterations in the renin–angiotensin system promote muscular inflammation, mitochondrial dysfunction, and apoptosis [119]; insulin resistance leads to perturbed metabolism and misrouted signaling [120].”
BackgroundKim, Y., Lee, J., Cho, E., Lee, H. S., Shin, S., Park, E. J., Baik, S. H., Lee, K. Y., & Kang, J. (2023) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13183 · Cited by 45
“These cytokines may mediate the redistribution of adipose tissue and intramuscular fat infiltration by inducing the differentiation of muscle progenitor cells to an adipocyte-like phenotype.(37,38) Based on these observations, myosteatosis and albumin may reflect cachexic status in different ways; thus, integrating th…”
BackgroundSarcopenia and cachexia: molecular mechanisms and therapeutic interventions
Wang, T., Zhou, D., & Hong, Z. (2025) · MedComm · doi:10.1002/mco2.70030 · Cited by 46
Differential control of muscle mass in type 1 and type 2 diabetes mellitus
Sala, D., & Zorzano, A. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1954-7 · Cited by 47
“together with an increase in factors that enhance protein degradation in this tissue, such as TNFa, IL-6, leptin and myostatin, may be involved in this process (reviewed in [127]).”
BackgroundAlalwan, T. A. (2020) · Geriatrics · doi:10.3390/geriatrics5010008 · Cited by 46
“Similarly, levels of growth hormone (GH) decline in an age-dependent fashion leading to numerous consequences for skeletal muscle structure and function [47].”
BackgroundPark, C., Do, J. G., Lee, Y., & Yoon, K. J. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-021232 · Cited by 46
Physiological Systems in Promoting Frailty
Perazza, L. R., Brown‐Borg, H. M., & Thompson, L. V. (2022) · Comprehensive physiology · doi:10.1002/cphy.c210034 · Cited by 76
Kim, J., Shin, S., & Kwon, E. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200729 · Cited by 39
Cushing’s syndrome: a model for sarcopenic obesity
Drey, M., Berr, C., Reincke, M., Fazel, J., Seißler, J., Schopohl, J., Bidlingmaier, M., Zopp, S., Reisch, N., Beuschlein, F., et al. (2017) · Endocrine · doi:10.1007/s12020-017-1370-x · Cited by 38
“Despite extensive advances in muscle research the pathomechanism of sarcopenia and particularly sarcopenic obesity is not well understood [17].”
BackgroundLaurentius, T., Kob, R., Fellner, C., Nourbakhsh, M., Bertsch, T., Sieber, C. C., & Bollheimer, L. C. (2019) · Disease Markers · doi:10.1155/2019/9140789 · Cited by 34
Self-citationBenavides-Rodriguez, L. E., García‐Hermoso, A., Rodrigues-Bezerra, D., Izquierdo, M., Correa‐Bautista, J. E., & Ramírez‐Vélez, R. (2017) · Nutrients · doi:10.3390/nu9070695 · Cited by 40
“In this sense, SO, represented by increased adiposity, has been associated with a defect in the insulin signaling pathway at a post-receptor level and impaired glucose transport through the insulin-regulated glucose 4 transporter pathway [53].”
BackgroundSarcopenic Obesity in Cancer Patients: Focus on Pathogenesis
Raffaello, W. M., & Kurniawan, A. (2020) · Indonesian Journal of Cancer · doi:10.33371/ijoc.v14i3.720 · Cited by 32
Sarcopenic Obesity Revisited: Insights From the Mr and Ms Os Cohort
Woo, J., & Leung, J. C. S. (2018) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2018.03.003 · Cited by 32
Cespiati, A., Meroni, M., Lombardi, R., Oberti, G., Dongiovanni, P., & Fracanzani, A. L. (2022) · Biomedicines · doi:10.3390/biomedicines10010182 · Cited by 33
“In turn, the adipose tissue itself releases several pro-inflammatory cytokines (referred to as adipokines) that recruit monocytes/macrophages, which infiltrate the adipose and muscle tissues, exacerbating the inflammatory pathways and muscle atrophy [72].”
BackgroundChung, T., Kwon, Y., Shim, J., & Lee, Y. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.10.032 · Cited by 32
Mizuno, N., Seko, Y., Kataoka, S., Okuda, K., Furuta, M., Takemura, M., Taketani, H., Hara, T., Umemura, A., Nishikawa, T., et al. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-018-1485-8 · Cited by 28
Morphological alterations of mouse skeletal muscles during early ageing are muscle specific
Messa, G. A. M., Piasecki, M., Hill, C., McPhee, J. S., Tallis, J. A., & Degens, H. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110684 · Cited by 32
The endocrinology of sarcopenia and frailty
Kamwa, V., Welch, C., & Hassan-Smith, Z. K. (2022) · Minerva Endocrinology · doi:10.23736/s2724-6507.20.03198-3 · Cited by 32
Cho, Y. K., Jung, H. N., Kim, E. H., Lee, M. J., Park, J., Lee, W. J., Kim, H., & Jung, C. H. (2023) · Obesity · doi:10.1002/oby.23733 · Cited by 28
Seko, Y., Mizuno, N., Okishio, S., Takahashi, A., Kataoka, S., Okuda, K., Furuta, M., Takemura, M., Taketani, H., Umemura, A., et al. (2019) · Hepatology Research · doi:10.1111/hepr.13321 · Cited by 23
Pasdar, Y., Darbandi, M., Rezaeian, S., Najafi, F., Hamzeh, B., & Bagheri, A. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2021.705055 · Cited by 25
Meisel, P., Eremenko, M., Holtfreter, B., Völzke, H., & Kocher, T. (2019) · Journal of Periodontology · doi:10.1002/jper.18-0733 · Cited by 26
Lee, M., Choi, Y., & Nam, T. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12125 · Cited by 26
“Additionally, an increase in body fat due to aging causes fat to be deposited in muscle tissue, and the accumulation of intramuscular fat can increase the secretion of inflammatory cytokines, such as TNF‑ α and IL‑6 (27,28).”
Yin, Y., Liu, J. Y. W., & Valimaki, M. A. (2023) · BMC Geriatrics · doi:10.1186/s12877-023-04327-w · Cited by 28
“Sarcopenic obesity is triggered by a variety of unhealthy lifestyles (e.g., a sedentary life and an unhealthy diet) and physiological factors (e.g., a decline in growth hormones, insulin resistance, an increase in oxidative stress), that occur during the ageing process [4–6].”
BackgroundLana, A., Struijk, E. A., Guallar‐Castillón, P., Martin-Moreno, J. M., Rodríguez‐Artalejo, F., & López‐García, E. (2016) · Age and Ageing · doi:10.1093/ageing/afw142 · Cited by 22
“In fact, older adults with sarcopenia or obesity are at higher risk of impaired physical function [12] probably because fat infiltrated in the muscle induces oxidative stress and chronic inflammation, which at the same time decreases skeletal muscle mass and strength [13, 14].”
BackgroundLippi, L., Alessandro de, S. I. R. E., Folli, A., Turco, A., Moalli, S., Marcasciano, M., Ammendolia, A., & Invernizzi, M. (2024) · Cancers · doi:10.3390/cancers16030521 · Cited by 28
“Studies have found that sarcopenia is often accompanied by an increase in the quantity of adipose tissue [58,59].”
BackgroundKim, D.-Y., Kim, C.-O., & Lim, H. (2017) · Nutrition · doi:10.1016/j.nut.2016.12.023 · Cited by 22
Shozi, S., Monyeki, M. A., Moss, S. J., & Pienaar, C. (2022) · African Journal of Primary Health Care & Family Medicine · doi:10.4102/phcfm.v14i1.3206 · Cited by 25
Dapagliflozin increases the lean-to total mass ratio in type 2 diabetes mellitus
Wolf, V. L. W., Breder, I. S. S., de Carvalho, L. S. F., Soares, A., Cintra, R. M. R., Barreto, J., Munhoz, D., Kimura-Medorima, S. T., Nadruz, W., Guerra‐Júnior, G., et al. (2021) · Nutrition and Diabetes · doi:10.1038/s41387-021-00160-5 · Cited by 17
Han, T., Yuan, T., Liang, X., Chen, N., Song, J., Zhao, X., Weng, Y., & Hu, Y. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s360942 · Cited by 20
“The main effect of such progress is the marked impairment of muscle mitochondria, reduced lipid β-oxidation, enhanced reactive oxygen species (ROS) production, and a disturbed inflammatory signaling pathway (mainly, mTOR blockage).(12,33,34) Moreover AT-skeletal muscle pro-inflammatory interconnection also exerts an i…”
BackgroundPrevalence of obesity and obesity-associated muscle wasting in patients on peritoneal dialysis
Guida, B., Trio, R., Maro, M. D., Memoli, A., Lauro, T. D., Belfiore, A., Santillo, M., & Cataldi, M. (2019) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.05.057 · Cited by 19
“It has to be mentioned, however, that criticisms have been raised on the inflammatory hypothesis of the genesis of sarcopenic obesity and that some authors consider cytokine plasma levels only as confounders of the real pathogenetic mechanism of this condition [56].”
BackgroundKEMMLER, W. K., Kohl, M., Fröhlich, M., Engelke, K., von Stengel, S., & Schoene, D. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.01014 · Cited by 23
How Do Skeletal Muscles Die? An Overview
Carmeli, E., Aizenbud, D., & Rom, O. (2015) · Advances in experimental medicine and biology · doi:10.1007/5584_2015_140 · Cited by 16
Kim, H. S., Lee, J., Kim, E. H., Lee, M. J., Bae, I. Y., Lee, W. J., Park, J., Kim, H., & Jung, C. H. (2023) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2022.0081 · Cited by 19
“These macrophages further release proinflammatory cytokines such as C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor α [30].”
BackgroundThe Role of Physical Activity and Nutrition in the Sarcopenia of Cirrhosis
Trovato, F. M., Aiello, F. C., Larocca, L., & Taylor-Robinson, S. D. (2016) · Journal of Functional Morphology and Kinesiology · doi:10.3390/jfmk1010118 · Cited by 18
“This process is also worsened with aging where lean muscle mass changes [27].”
BackgroundYoo, T. K., Rhim, H. C., Lee, Y., Yoon, K. J., & Park, C. (2022) · Scientific Reports · doi:10.1038/s41598-022-16401-1 · Cited by 15
Xiang, S., Li, Y., Li, Y., Zhang, J., Pan, W., Lu, Y., & Liu, S. (2023) · The journal of nutrition health & aging · doi:10.1007/s12603-023-1967-0 · Cited by 17
“This exacerbates the inflammatory state of the body and leads to skeletal muscle atrophy by increasing apoptosis and upregulating the decay of the protein body of silk protein, further impairing the body’s energy metabolism and glucose homeostasis (33, 34).”
Booranasuksakul, U., Tsintzas, K., Macdonald, I. A., Stephan, B. C. M., & Siervo, M. (2024) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2024.08.017 · Cited by 16
Moderators of skeletal muscle maintenance are compromised in sarcopenic obese mice
Brown, L. A., Perry, R. A., Haynie, W. S., Lee, D. E., Rosa‐Caldwell, M. E., Brown, J. L., Greene, N. P., Wolchok, J. C., & Washington, T. A. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111404 · Cited by 14
Surov, A., Wienke, A., Borggrefe, J., Hinnerichs, M. S., Seidensticker, R., Öcal, O., Schütte, K., Zech, C. J., Loewe, C., van Delden, O. M., et al. (2024) · United European Gastroenterology Journal · doi:10.1002/ueg2.12627 · Cited by 12
“38,39 These mechanisms can explain our results and show that associations between body composition, in partikular low skeletal muscle quality, and tumor behavior are very complex and harbor potential aspects for further investigations.”
BackgroundPeng, L., Xiang, Q., Jia, G., & Yin, R. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1540272 · Cited by 13
Immunogenetic Aspects of Sarcopenic Obesity
Mazurkiewicz, Ł., Czernikiewicz, K., & Grygiel‐Górniak, B. (2024) · Genes · doi:10.3390/genes15020206 · Cited by 13
“It enhances the production of IL-10 and IL-1Ra and reduces the amount of TNF-α [55,62,63].”
BackgroundIwadare, T., Kimura, T., Kunimoto, H., Tanaka, N., Wakabayashi, S., Yamazaki, T., Okumura, T., Kobayashi, H., Yamashita, Y., Sugiura, A., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10112806 · Cited by 13
“High body fat mass %, low soft lean mass %, and low SKM mass % have been reported as risk factors for physical activity impairment and diminished clinical outcome [30].”
BackgroundGuan, Z., Stephan, B. C. M., Donini, L. M., Prado, C. M. M., Sim, M., & Siervo, M. (2024) · Proceedings of The Nutrition Society · doi:10.1017/s0029665124007559 · Cited by 14
“An ageing-related decline in growth hormone (GH) levels leading to numerous adverse consequences for skeletal muscle structure and strength; such decline also reduces liver-derived insulin-like growth factor-I (IGF-I), a principal regulator of muscle mass (67,68) .”
Endocrinological aspects of sarcopenic obesity
Minnetti, M., Poggiogalle, E., Frigerio, F., Piciocchi, C., Pierantozzi, G., Vincenzo, O. D., Pinto, A., Gianfrilli, D., Isidori, A. M., Migliaccio, S., et al. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2626085 · Cited by 14
“Also, a higher fat mass results in activation of macrophages, inflammatory T lymphocytes, and mast cells, creating a proinflammatory state [22].”
Lee, Y. M., & Kim, O. S. (2017) · Physical Activity and Nutrition · doi:10.20463/jenb.2017.0059 · Cited by 10
Silveira, É. A., de Souza, J. D., Santos, A. S. E. A. D. C., Canheta, A. B. D. S., Pagotto, V., & Noll, M. A. (2020) · Archives of Public Health · doi:10.1186/s13690-020-00454-7 · Cited by 13
Cao, Y., Heng, Y., Song, M., Nie, T., Liu, Z., Xu, J., Wu, X., Qin, L., Liu, T., Wu, F., et al. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.08.007 · Cited by 13
The Importance of Nutrition in a Conceptual Framework of Frailty Syndrome
Zukeran, M. S., & Ribeiro, S. M. L. (2017) · Current Nutrition Reports · doi:10.1007/s13668-017-0195-9 · Cited by 8
Meisel, P., Daboul, A., Bülow, R., Eremenko, M., Völzke, H., Biffar, R., & Kocher, T. (2023) · Odontology · doi:10.1007/s10266-023-00785-1 · Cited by 11
“It is also strongly associated with obesity [12].”
BackgroundChen, F., Du, N., Hu, J., Ning, F., Mei, X., Li, Q., & Peng, L. (2020) · PubMed · Cited by 11
Takayama, M., Azuma, K., Hayashi, K., Shimizu‐Hirota, R., Makino, K., Bessho, R., Yoshida, T., Kashiwagi, K., Hirose, H., Inoue, N., et al. (2017) · Health Evaluation and Promotion · doi:10.7143/jhep.44.587 · Cited by 8
Multiomics Picture of Obesity in Young Adults
Kiseleva, O. I., Pyatnitskiy, M. A., Arzumanian, V. A., Kurbatov, I. Y., Ilinsky, V. V., Ilgisonis, E. V., Plotnikova, O. A., KhKh, S., Tutelyan, V. A., Nikityuk, D. B., et al. (2024) · Biology · doi:10.3390/biology13040272 · Cited by 8
“Significantly, hyperglycemia, a characteristic feature of obesity, has been correlated with muscle atrophy [67,68].”
BackgroundChoi, J., & Yang, Y.-M. (2023) · Journal of Health Population and Nutrition · doi:10.1186/s41043-023-00443-w · Cited by 7
“Age-related augmented visceral fat and muscle fat infiltration boost insulin resistance and inflammation, which, through a vicious cycle, affects skeletal and muscle metabolism alterations and dysregulation leading to osteoporosis and sarcopenia [50].”
BackgroundBischoff, S. C., & Volynets, V. (2016) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2016.05.018 · Cited by 6
Salinas‐Rodríguez, A., Rivera‐Almaraz, A., & Manrique-Espinoza, B. S. (2025) · Experimental Gerontology · doi:10.1016/j.exger.2025.112752 · Cited by 8
“Several factors have been associated with SO, including insulin resistance, dyslipidemia, inflammation, unhealthy dietary habits, and chronic conditions, such as hypertension (Kob et al., 2015a).”
Influential
Metadata
- Authors
- Kob, R., Bollheimer, L. C., Bertsch, T., Fellner, C., Djukic, M., Sieber, C. C., & Fischer, B. E.
- Affiliations
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Paracelsus Medizinische Privatuniversität (DE)
- University Hospital Regensburg (DE)
- Universitätsmedizin Göttingen (DE)
- Corresponding author
- Fischer, Barbara E.
- ORCID
- Venue
- Biogerontology
- Published
- 2014-11-07
- Volume
- 16
- Issue
- 1
- Pages
- 15-29
- ISSN
- 1389-5729 (ISSN-L)
- 1573-6768
- OpenAlex
- W2087089023
- Cited by
- 151
- References
- 125
- Citations by year
- 2026: 7 · 2025: 18 · 2024: 14 · 2023: 15 · 2022: 14 · 2021: 9 · 2020: 18 · 2019: 10 · 2018: 11 · 2017: 13 · 2016: 12 · 2015: 10
- FWCI
- 1.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Biogerontology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bayerische Forschungsstiftung
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- sarcopenic obesity, sarcopenia, obesity, pathogenesis, lipotoxicity, oxidative stress, apoptosis, inflammatory cytokines, C-reactive protein, interleukin-6, hypothalamic-pituitary axis, caloric restriction, insulin resistance, skeletal muscle, muscle progenitor cells, adipogenesis, muscle atrophy, aging
- MeSH terms
- Aging, Humans, Insulin Resistance, Obesity, Signal Transduction, Muscle, Skeletal, Muscle Weakness, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.